Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The preleukemic syndrome.

J J Biemer

    Annals of Clinical and Laboratory Science
    |March 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Preleukemic syndrome (PLS) is a recognized condition with diverse presentations. Early recognition aids in managing risks of developing acute nonlymphocytic leukemia (ANLL) or non-leukemic complications.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Gene rearrangements in malignant lymphomas.

    Annals of clinical and laboratory science·1994
    Same author

    Malignant lymphomas associated with immunodeficiency states.

    Annals of clinical and laboratory science·1990
    Same author

    Control of oral anticoagulant therapy.

    Annals of clinical and laboratory science·1988
    Same author

    Hepatic manifestations of lymphomas.

    Annals of clinical and laboratory science·1984
    Same author

    Transient reticulocytopenia in viral illness.

    Annals of clinical and laboratory science·1982
    Same author

    Heterotopic pharyngeal brain.

    Archives of otolaryngology (Chicago, Ill. : 1960)·1981
    Same journal

    <i>Letter to the Editor:</i> Detection of <i>Chlamydia trachomatis</i> Immunoglobulin E Antibody in Human Sera.

    Annals of clinical and laboratory science·2026
    Same journal

    Comparison of the DNA Preservation Capacity of Two Methods for the Long-Term Cryopreservation of Whole Blood Samples.

    Annals of clinical and laboratory science·2026
    Same journal

    Recurrence of Primary Mediastinal Yolk Sac Tumor with Brain Metastases: A Case Report and Literature Review.

    Annals of clinical and laboratory science·2026
    Same journal

    Intraoperative Imprint Cytology of <i>SMARCB1</i>-Mutant Desmoplastic Myxoid Tumor of the Pineal Region: A Case Report with Cytologic Differential Diagnosis and Literature Review.

    Annals of clinical and laboratory science·2026
    Same journal

    Bergenin Suppresses Glycolysis and Malignant Progression in Breast Cancer via the IGF1R-MAPK Signaling Pathway.

    Annals of clinical and laboratory science·2026
    Same journal

    Network Pharmacology and <i>in vitro</i> Experimental Validation Reveal the Anticancer Mechanisms of Cichoric Acid in Cervical Cancer.

    Annals of clinical and laboratory science·2026
    See all related articles

    Area of Science:

    • Hematology
    • Oncology

    Background:

    • Preleukemic syndrome (PLS) presents a spectrum of clinical and laboratory findings.
    • Recognition of PLS has improved, aiding in patient management.

    Purpose of the Study:

    • To characterize the clinical and laboratory findings of preleukemic syndrome (PLS).
    • To assess the risk of progression to acute nonlymphocytic leukemia (ANLL) and non-leukemic complications in PLS patients.

    Main Methods:

    • Clinical and laboratory data review of patients diagnosed with PLS.
    • Cytogenetic analysis and marrow hematopoietic cell culture to identify neoplastic clonal proliferation.

    Main Results:

    • Approximately 25% of PLS patients progress to overt ANLL within 2-3 years.

    Related Experiment Videos

  • 40% of PLS patients die from non-leukemic complications related to cytopenias within a similar timeframe.
  • A significant portion of PLS patients remain stable with prolonged survival.
  • Conclusions:

    • PLS is characterized by an established neoplastic clonal stem cell proliferation.
    • Cytogenetic analysis and marrow cell culture can frequently demonstrate this proliferation in PLS.
    • Early identification and management are crucial for PLS patients due to risks of leukemia and complications.